Back to account

Freyr · Account Report

NovaGene Therapeutics

novagenetherapeutics.com

Generated
Jul 22, 2026

Industry

Biotechnology

Geography

United States (Princeton, NJ)

Size

Mid-size

Owner

Suren Dheen

Competitor

Open value

$270K

Account summary

Gene-therapy biotech, first BLA in 18 months, lean RA team.

Buying committee (1)

  • Dana WhitfieldVP Regulatory Affairs

Deals (1)

  • Clinical Trial Regulatory SupportQualified · $270K

Recommended Freyr services

  • Clinical Trial Regulatory Support
  • Regulatory Intelligence

Recent activity

  • Interested — Wants IND-to-BLA roadmap.Jul 3, 2026 • 1:49 PM